Savara (SVRA) Net Equity Issued and Repurchased (2009 - 2026)
Savara (SVRA) posted Net Equity Issued and Repurchased of $194,000 for Q2 2026, up 198.5% from $65,000 a year earlier and up 331.1% from the prior quarter.
Savara (SVRA) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Savara was $140.59 million, up 49.1% year-over-year; for FY2025, it was $140.58 million, up 49.3% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 101.8% (FY2020 to FY2025).
- In prior years, Savara's Net Equity Issued and Repurchased was $94.15 million in FY2024, $283,000 in FY2023, $2,000 in FY2022 (-100.0%) and $122.25 million in FY2021.
- Quarterly Net Equity Issued and Repurchased has run from a low of $10,000 in Q3 2021 to a high of $140.35 million in Q4 2025 over five years.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last five quarters, with growth averaging 160.2%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2025, with growth of 490.9%; the weakest was Q4 2021, with a decline of 95.4%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Savara | 1.09 Bn | 407.27 Mn | - | 17,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 17,000.00 |
| Jun 30, 2026 | 194,000.00 |
| Mar 31, 2026 | 45,000.00 |
| Dec 31, 2025 | 140.35 Mn |
| Jun 30, 2025 | 65,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | 94.04 Mn |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | 63,000.00 |
| Jun 30, 2023 | 104,000.00 |
| Mar 31, 2023 | 27,000.00 |
| Dec 31, 2021 | 84,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 324,000.00 |
| Mar 31, 2021 | 121.83 Mn |
| Dec 31, 2020 | 1.83 Mn |
| Jun 30, 2020 | 2.33 Mn |
Savara Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SVRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();